Adalimumab is a promising therapy for children with Crohn's disease
Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the ...
Aug 6, 2012
0
0